Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 29;11(4):757.
doi: 10.3390/vaccines11040757.

Improving the Quality of Healthcare Provision Regarding HPV Immunization for Women with CIN2+ Lesions: The Experience of the Veneto Region in Italy

Affiliations

Improving the Quality of Healthcare Provision Regarding HPV Immunization for Women with CIN2+ Lesions: The Experience of the Veneto Region in Italy

Anna De Polo et al. Vaccines (Basel). .

Abstract

HPV is the most common cause of sexually-transmitted infections the world over. The aim of this study was to assess the impact of a healthcare quality improvement strategy designed to increase the rate of vaccination against HPV in women diagnosed with cervical lesions graded as CIN2 or higher (CIN2+) during routine screening. The Veneto Regional Health Service developed a 22-item questionnaire to measure the gap between ideal procedure and real practice regarding the offer of vaccination against HPV for women undergoing routine cervical screening. The questionnaire was administered to nine expert doctors, one at each of the region's Local Health Units (LHUs). An additional specific assessment concerned the quality of the related web pages available on the LHU websites. Strategies to close the gap between ideal procedure and real practice were decided collegially, and a checklist to support good practices was developed and shared with operators at the LHUs. Changes in practice were measured using data relating to women diagnosed with CIN2+ lesions extracted from the regional oncological screening database before and after the publication of a Regional Procedure on the topic. The LHUs differed considerably in how they managed each step, in terms of training for healthcare personnel, organization and assessment of the pathway from cervical screening to HPV vaccination, and in dedicated website communication. After implementing the quality improvement strategy, the proportion of women given a first dose of HPV vaccine within 3 months of being diagnosed with CIN2+ lesions at 1st-level screening rose to 50% (compared with 30.85% beforehand), and the median time elapsing between a diagnosis of CIN2+ lesion and a first dose of HPV vaccine dropped from 158 to 90 days. These findings underscore the importance of providing training to promote vaccination for general practitioners and other clinicians. The study also confirms the need for more efforts in communication to ensure that any citizen has the opportunity to access preventive healthcare.

Keywords: CIN2+; HPV vaccine; cervical screening; human papillomavirus; preventive healthcare; quality improvement.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Conceptual framework of the Continuous Quality Improvement (CQI) project carried out by the Veneto Region Prevention Directorate regarding the HPV vaccination in women diagnosed with CIN2+.
Figure 2
Figure 2
Overall results of the survey by Local Health Unit (LHU).

Similar articles

References

    1. Manini I., Montomoli E. Epidemiology and prevention of Human Papillomavirus. Ann Ig. 2018;30:28–32. doi: 10.7416/AI.2018.2231. - DOI - PubMed
    1. IARC—Cancer Over Time. [(accessed on 8 August 2022)]. Available online: https://gco.iarc.fr/overtime/en/dataviz/trends?populations=38000&sexes=1....
    1. Khairkhah N., Bolhassani A., Najafipour R. Current and future direction in treatment of HPV-related cervical disease. J. Mol. Med. 2022;100:829–845. doi: 10.1007/s00109-022-02199-y. - DOI - PMC - PubMed
    1. Arbyn M., Xu L. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials. Expert Rev. Vaccines. 2018;17:1085–1091. doi: 10.1080/14760584.2018.1548282. - DOI - PubMed
    1. DGRV n. 576 del 04 Maggio 2021 “Ridefinizione del Calendario di Invito a Screening Cervicale Delle Donne Venticinquenni, Vaccinate per Papilloma Virus (HPV) Nelle Campagne Vaccinali Delle 12enni, di cui alla D.G.R. n. 772 del 27/05/2014 e D.G.R. n. 760 del 14/05/2015, in Tema di Prevenzione e Diagnosi Precoce Dei Tumori” e Successiva Modifica con DGRV n. 804 del 22 Giugno. 2021. [(accessed on 14 March 2023)]. Available online: http://bur.regione.veneto.it/BurvServices/Pubblica/DettaglioDgr.aspx?id=....

LinkOut - more resources